BG · Q1 2026 Earnings

Narrative arc: Viterra waiting game → Viterra closes, EPS held → Viterra dilutive, EPS cut → Synergies absorbed by financing drag → Synergies ahead of plan, guide raised on operational beat

Three quarters ago management was pleading for time to integrate Viterra. Two quarters ago Viterra was "mildly dilutive" to 2025 and the EPS algorithm had been deferred to a March Investor Day. Last quarter the FY2026 guide of $7.50–$8.00 confirmed Bunge was structurally a $7–$8 EPS business once financing absorbed synergies. This quarter management is asserting "[Bunge] today is stronger, more agile, and better positioned than at any point in our history." That sentence is the inflection — and it lands alongside a $1.50 EPS midpoint raise that, if it holds, validates the combined-company earnings power in a way the last two guides did not.

The Viterra synergy framing has gone from "running on plan" to running ahead. Last quarter management reported $190M of realized FY2026 synergies against the prior target — already ahead, but presented quietly. This quarter the message is explicit: "Viterra cost synergies are running ahead of plan, and we've identified significant network and commercial opportunities." That second clause — "network and commercial opportunities" — is the first acknowledgment that there is incremental synergy beyond the cost program, which had previously been the ceiling on the integration story. It is the strongest argument that the $9.00–$9.50 guide has further upside.

The half-year split has been recut in a way that should comfort the bear case from last quarter. Last quarter's 30/70 H1/H2 split implied a steep Q3–Q4 hockey stick on top of an already-cautious guide, with management's prior Q1 outlook in the ~$0.80–$0.90 range (confirmed on this call as the "low 80 cent range"). This quarter management states "now we're looking at the year to be 40% first half, 60% second half," and further breaks H2 into roughly 45/55 Q3/Q4. On the new $9.25 midpoint, that implies H1 of ~$3.70 and H2 of ~$5.55. The raise is being financed by a Q1 beat that has already happened (Q1 came in ~$1.00 above the prior ~$0.80–$0.90 outlook), not by a hopeful back-half.

The "system advantage" articulation has tightened from generic to specific. Two quarters ago "integrated platform" was a slogan; last quarter it was defended as protection against financing drag; this quarter management describes "margin can move around between origination, processing, merge and refining and distribution. And with our larger global system, our team now has, whether it's our origination assets, our storage assets, our distribution assets, to point them to where the most value can be created." That is the first time management has described the platform as an active margin-routing system rather than a portfolio of optionality — a meaningfully different claim about how the company makes money in a volatile environment.

RVO has flipped from policy-as-hedge to policy-as-tailwind. Last quarter management explicitly built the guide on forward curves with no RVO upside embedded. This quarter: "the market has set up where we've got clarity in the U.S. around the RBO, which has been very helpful…And that sends the right signal for mix of crop and production. So it is a good environment." That clarity is now in the FY guide. The optionality argument has been monetized into the EPS raise — meaning the next catalyst is execution, not policy.

What hasn't changed: hedging language remains heavy on H2 visibility. Management still flags "significant uncertainty remains, particularly in the second half of the year," "it's hard to see when things are going to turn," and "a lot of open switches on how this will play out." The guide has been raised on Q1 outperformance and synergy momentum; the H2 portion is still a managed projection on inverted crush curves.